| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.15B | 91.95B | 91.68B | 80.17B | 68.82B | 70.44B |
| Gross Profit | 16.72B | 15.36B | 11.65B | 9.05B | 8.46B | 8.41B |
| EBITDA | 9.77B | 9.29B | 5.77B | 4.37B | 3.52B | 3.18B |
| Net Income | 6.91B | 6.23B | 3.71B | 2.48B | 1.86B | 1.82B |
Balance Sheet | ||||||
| Total Assets | 70.56B | 80.86B | 84.01B | 78.94B | 72.08B | 71.50B |
| Cash, Cash Equivalents and Short-Term Investments | 13.12B | 18.53B | 18.77B | 17.67B | 19.51B | 16.03B |
| Total Debt | 4.70B | 3.99B | 3.55B | 3.36B | 3.88B | 4.51B |
| Total Liabilities | 29.48B | 38.83B | 45.25B | 43.56B | 37.72B | 37.83B |
| Stockholders Equity | 41.08B | 42.03B | 38.76B | 35.38B | 34.36B | 33.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -97.00M | 1.72B | -1.38B | 4.45B | -1.75B |
| Operating Cash Flow | 0.00 | 1.28B | 2.01B | -34.00M | 4.65B | -1.46B |
| Investing Cash Flow | 0.00 | 612.00M | -304.00M | -481.00M | 89.00M | -170.00M |
| Financing Cash Flow | 0.00 | -1.53B | -1.29B | -1.35B | -1.30B | -1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥255.76B | 9.64 | 8.91% | 3.85% | 1.48% | 8.86% | |
78 Outperform | ¥112.83B | 15.71 | ― | 4.64% | 3.99% | -28.28% | |
78 Outperform | ¥104.58B | 13.49 | ― | 4.20% | 3.00% | 58.58% | |
77 Outperform | ¥90.67B | 8.96 | ― | 3.82% | 3.68% | -46.19% | |
76 Outperform | ¥190.33B | 11.03 | ― | 2.50% | -2.46% | -10.72% | |
67 Neutral | ¥91.95B | 17.07 | ― | 3.77% | -5.87% | 24.10% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |